Target the gene, silence the disease
Location: United States, Kentucky, Lexington
Employees: 201-500
Total raised: $45M
Founded date: 1989
Investors 1
| Date | Name | Website |
| - | Aquilo Cap... | aquilocapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2016 | - | $45M | - |
Mentions in press and media 20
| Date | Title | Description |
| 01.09.2026 | Spider-Man Brand New Day: Wellesley’s 2025 Quantum Study Challenged Jean Grey’s Physics Objection | By William Chan Published: Sep 01 2026, 11:40 AM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 08.12.2025 | Arrowhead Hits the Mark ‘Important step’ for Arrowhead Redemplo: Targeting a rare disease Expanded Redemplo uses and markets Sarepta cash infusion | - |
| 20.07.2025 | S&P 500 posts first close above 6,300, Nasdaq hits a record ahead of big tech earnings: Live updates | The S&P 500 moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments in trade. The broad market index rose 0.14% and closed at 6,305.60 — marking the first time it ended a session a... |
| 21.12.2022 | Arrowhead Pharmaceuticals Receives $25M Payment | - |
| 14.10.2022 | Wisconsin-Japan Biohealth Summit showcases international collaboration | Guest post contributed by BioForward Across the globe, life science technology advancements are accelerating to promote better health. The recent Wisconsin-Japan Biohealth Summit, designed to raise awareness of current collaborations while ... |
| 12.07.2022 | An Epic in miniature: CRISPR pioneer's startup reels in $55M to use tiny Cas for epigenetic engineering | CRISPR co-inventor Stanley Qi, Ph.D., is out with a new biotech that wants to make a big splash by going small. The startup, Epic Bio, corralled a investor syndicate willing to bet $55 million on its vision to use the smallest known Cas pro... |
| 18.05.2022 | Wisconsin’s biotech strength leverages major drug company expansion | Concept drawing of Arrowhead Pharmaceuticals’ new Verona campus When Arrowhead Pharmaceuticals embarked on a $220 million expansion in Wisconsin, WEDC partnered with the firm to help it become a reality. The project, which has broken ground... |
| 11.05.2022 | Wisconsin giving Arrowhead Pharmaceuticals some cheddar as their new manufacturing site receives several million in state and local tax benefits | Arrowhead Pharmaceuticals is getting a leg up from Wisconsin officials on a new building project. The company has outlined a set of incentives that have become quite common as states look to compete for new manufactur... |
| 25.04.2022 | Vivo Capital pitches $60M to bring Arrowhead's RNAi meds to China via joint venture | Generally speaking, any biotech hoping to have a presence in China has a number of options. One could out-license its drugs to one of the transpacific players set up explicitly to be a bridge between Western medicines an... |
| 23.12.2021 | Arrowhead adds newest facility to its Midwest hub in RNAi drug production push | Arrowhead Pharmaceuticals has purchased 13 acres of land in Wisconsin’s Verona Technology Park and will build a 140,000-square-foot drug manufacturing facility. The company will spend between $200 million and $250 mil... |
Show more